T. Rowe Price Associates
MMSI icon

T. Rowe Price Associates’s Merit Medical Systems MMSI Stock Holding History

T. Rowe Price Associates’s Portfolio MMSI Stock Details MMSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.1M Buy
654,970
+10,107
+2% +$789K 0.01% 800
2025
Q4 		$56.8M Buy
644,863
+4,016
+0.6% +$342K 0.01% 775
2025
Q3 		$53.3M Sell
640,847
-91,497
-12% -$7.97M 0.01% 791
2025
Q2 		$68.5M Sell
732,344
-19,686
-3% -$1.87M 0.01% 650
2025
Q1 		$79.5M Sell
752,030
-20,849
-3% -$2.15M 0.01% 598
2024
Q4 		$74.8M Sell
772,879
-3,295
-0.4% -$328K 0.01% 639
2024
Q3 		$76.7M Sell
776,174
-4,305
-0.6% -$394K 0.01% 628
2024
Q2 		$67.1M Sell
780,479
-58,364
-7% -$4.59M 0.01% 630
2024
Q1 		$63.5M Buy
838,843
+22,077
+3% +$1.7M 0.01% 658
2023
Q4 		$62M Sell
816,766
-397
-0% -$27.7K 0.01% 642
2023
Q3 		$56.4M Buy
817,163
+2,573
+0.3% +$185K 0.01% 646
2023
Q2 		$68.1M Buy
814,590
+7,104
+0.9% +$578K 0.01% 618
2023
Q1 		$59.7M Sell
807,486
-58,486
-7% -$4.1M 0.01% 637
2022
Q4 		$61.2M Sell
865,972
-20,218
-2% -$1.35M 0.01% 610
2022
Q3 		$50.1M Buy
886,190
+2,344
+0.3% +$135K 0.01% 645
2022
Q2 		$48M Buy
883,846
+6,307
+0.7% +$385K 0.01% 887
2022
Q1 		$58.4M Buy
877,539
+11,375
+1% +$684K 0.01% 919
2021
Q4 		$54M Buy
866,164
+943
+0.1% +$63.2K ﹤0.01% 979
2021
Q3 		$62.1M Sell
865,221
-1,774
-0.2% -$120K 0.01% 937
2021
Q2 		$56.1M Buy
866,995
+28,638
+3% +$1.77M 0.01% 987
2021
Q1 		$50.2M Buy
838,357
+62,074
+8% +$3.56M 0.01% 1000
2020
Q4 		$43.1M Buy
776,283
+63,556
+9% +$3.28M ﹤0.01% 1011
2020
Q3 		$31M Sell
712,727
-298
-0% -$13.5K ﹤0.01% 1028
2020
Q2 		$32.5M Sell
713,025
-1,347
-0.2% -$54.4K ﹤0.01% 989
2020
Q1 		$22.3M Buy
714,372
+677,012
+1,812% +$24.1M ﹤0.01% 1032
2019
Q4 		$1.17M Buy
37,360
+7,026
+23% +$201K ﹤0.01% 1824
2019
Q3 		$924K Buy
30,334
+245
+0.8% +$9.91K ﹤0.01% 1858
2019
Q2 		$1.79M Buy
30,089
+1,739
+6% +$99.7K ﹤0.01% 1628
2019
Q1 		$1.75M Buy
28,350
+4,440
+19% +$252K ﹤0.01% 1631
2018
Q4 		$1.33M Buy
23,910
+5,802
+32% +$345K ﹤0.01% 1693
2018
Q3 		$1.11M Buy
18,108
+185
+1% +$10.6K ﹤0.01% 1844
2018
Q2 		$918K Buy
17,923
+270
+2% +$13.4K ﹤0.01% 1880
2018
Q1 		$801K Buy
17,653
+31
+0.2% +$1.4K ﹤0.01% 1880
2017
Q4 		$761K Buy
17,622
+450
+3% +$18.9K ﹤0.01% 1912
2017
Q3 		$727K Hold
17,172
– – ﹤0.01% 1928
2017
Q2 		$655K Buy
17,172
+16
+0.1% +$535 ﹤0.01% 1957
2017
Q1 		$496K Hold
17,156
– – ﹤0.01% 2071
2016
Q4 		$455K Buy
17,156
+520
+3% +$12.6K ﹤0.01% 2091
2016
Q3 		$404K Sell
16,636
-7,580
-31% -$175K ﹤0.01% 2090
2016
Q2 		$480K Hold
24,216
– – ﹤0.01% 1975
2016
Q1 		$448K Buy
24,216
+5,410
+29% +$93.8K ﹤0.01% 2023
2015
Q4 		$350K Buy
18,806
+100
+0.5% +$2.01K ﹤0.01% 2099
2015
Q3 		$447K Buy
18,706
+3,600
+24% +$84.7K ﹤0.01% 2003
2015
Q2 		$325K Hold
15,106
– – ﹤0.01% 2165
2015
Q1 		$291K Hold
15,106
– – ﹤0.01% 2205
2014
Q4 		$262K Hold
15,106
– – ﹤0.01% 2233
2014
Q3 		$179K Hold
15,106
– – ﹤0.01% 2374
2014
Q2 		$228K Hold
15,106
– – ﹤0.01% 2305
2014
Q1 		$216K Hold
15,106
– – ﹤0.01% 2292
2013
Q4 		$238K Hold
15,106
– – ﹤0.01% 2251
2013
Q3 		$183K Sell
15,106
-2,200
-13% -$28.3K ﹤0.01% 2292
2013
Q2 		$193K Buy
+17,306
New +$185K ﹤0.01% 2220

Other funds holding MMSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

T. Rowe Price Associates's MMSI Position: Q1 2026 in Review

T. Rowe Price Associates increased its Merit Medical Systems (MMSI) stake by 1.6% in Q1 2026, buying an estimated $789K and bringing the position to 654,970 shares worth $45.1M. The position accounts for 0.01% of the portfolio, ranked #800.

T. Rowe Price Associates first reported a position in MMSI in Q2 2013 and has held it in 52 quarters since. The position peaked at $79.5M in Q1 2025. 399 funds tracked by Wall St. Rank hold MMSI as of Q1 2026.

  • T. Rowe Price Associates held 654,970 shares of Merit Medical Systems worth $45.1M as of Q1 2026.
  • T. Rowe Price Associates bought 10,107 Merit Medical Systems shares in Q1 2026, an estimated $789K.
  • Merit Medical Systems made up 0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #800 holding.
  • T. Rowe Price Associates first reported a position in Merit Medical Systems in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Merit Medical Systems position peaked at $79.5M in Q1 2025.
  • 399 funds tracked by Wall St. Rank held Merit Medical Systems as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.